Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma?

REFERENCES

1. 1.↵
   2. Dagher AP,
   3. Smirniotopoulos J

   . Tumefactive demyelinating lesions. Neuroradiology 1996;38:560–65 doi:10.1007/BF00626098 pmid:8880719

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Given CA 2nd.,
   3. Stevens BS,
   4. Lee C

   . The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol 2004;182:195–99 doi:10.2214/ajr.182.1.1820195 pmid:14684539

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Masdeu JC,
   3. Quinto C,
   4. Olivera C, et al

   . Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 2000;54:1427–33 doi:10.1212/WNL.54.7.1427 pmid:10751251

   Abstract/FREE Full Text
4. 4.↵
   2. Blasel S,
   3. Pfeilschifter W,
   4. Jansen V, et al

   . Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas. J Neurol 2011;258:113–22 doi:10.1007/s00415-010-5703-4 pmid:20803026

   CrossRefPubMed
5. 5.↵
   2. Zagzag D,
   3. Miller DC,
   4. Kleinman GM, et al

   . Demyelinating disease versus tumor in surgical neuropathology: clues to a correct pathological diagnosis. Am J Surg Pathol 1993;17:537–45 doi:10.1097/00000478-199306000-00001 pmid:8333553

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Hu W,
   3. Lucchinetti CF

   . The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol 2009;31:439–53 doi:10.1007/s00281-009-0178-z pmid:19779719

   CrossRefPubMed
7. 7.↵
   2. Neelima R,
   3. Krishnakumar RK,
   4. Nair MD, et al

   . Tumefactive demyelinating lesions: a clinicopathological correlative study. Indian J Pathol Microbiol 2012;55:496–500 doi:10.4103/0377-4929.107788 pmid:23455787

   CrossRefPubMed
8. 8.↵
   2. Bahn MM

   . Invariant and orthonormal scalar measures derived from magnetic resonance diffusion tensor imaging. J Magn Reson 1999;141:68–77 doi:10.1006/jmre.1999.1875 pmid:10527745

   CrossRefPubMed
9. 9.↵
   2. Green HA,
   3. Peña A,
   4. Price CJ, et al

   . Increased anisotropy in acute stroke: a possible explanation. Stroke 2002;33:1517–21 doi:10.1161/01.STR.0000016973.80180.7B pmid:12052984

   Abstract/FREE Full Text
10. 10.↵
    2. Peña A,
    3. Green HA,
    4. Carpenter TA, et al

    . Enhanced visualization and quantification of magnetic resonance diffusion tensor imaging using the p:q tensor decomposition. Br J Radiol 2006;79:101–09 doi:10.1259/bjr/24908512 pmid:16489190

    Abstract/FREE Full Text
11. 11.↵
    2. Price SJ,
    3. Peña A,
    4. Burnet NG, et al

    . Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas. Eur Radiol 2004;14:1909–17 pmid:15221264

    PubMed
12. 12.↵
    2. Wang W,
    3. Steward CE,
    4. Desmond PM

    . Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy. AJNR Am J Neuroradiol 2009;30:203–08 pmid:18842762

    Abstract/FREE Full Text
13. 13.↵
    2. Toh CH,
    3. Castillo M,
    4. Wong AM, et al

    . Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008;29:471–75 doi:10.3174/ajnr.A0872 pmid:18065516

    Abstract/FREE Full Text
14. 14.↵
    2. Toh CH,
    3. Wei KC,
    4. Ng SH, et al

    . Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging. AJNR Am J Neuroradiol 2012;33:846–51 doi:10.3174/ajnr.A2871 pmid:22173757

    Abstract/FREE Full Text
15. 15.↵
    2. Law M,
    3. Yang S,
    4. Wang H, et al

    . Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98 pmid:14625221

    Abstract/FREE Full Text
16. 16.↵
    2. Hakyemez B,
    3. Erdogan C,
    4. Ercan I, et al

    . High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005;60:493–502 doi:10.1016/j.crad.2004.09.009 pmid:15767107

    CrossRefPubMed
17. 17.↵
    2. Cha S,
    3. Pierce S,
    4. Knopp EA, et al

    . Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001;22:1109–16 pmid:11415906

    Abstract/FREE Full Text
18. 18.↵
    The Area Under an ROC Curve. http://gim.unmc.edu/dxtests/ROC3.htm. Accessed February 2, 2016.
19. 19.↵
    2. Lucchinetti CF,
    3. Gavrilova RH,
    4. Metz I, et al

    . Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 2008;131:1759–75 doi:10.1093/brain/awn098 pmid:18535080

    Abstract/FREE Full Text
20. 20.↵
    2. Mabray MC,
    3. Cohen BA,
    4. Villanueva-Meyer JE, et al

    . Performance of apparent diffusion coefficient values and conventional MRI features in differentiating tumefactive demyelinating lesions from primary brain neoplasms. AJR Am J Roentgenol 2015;205:1075–85 doi:10.2214/AJR.14.13970 pmid:26496556

    CrossRefPubMed
21. 21.↵
    2. Saini J,
    3. Chatterjee S,
    4. Thomas B, et al

    . Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Acta Radiol 2011;52:1159–68 doi:10.1258/ar.2011.110007 pmid:22025739

    CrossRefPubMed
22. 22.↵
    2. Lassmann H

    . Pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am 2008;18:563–76, ix doi:10.1016/j.nic.2008.06.005 pmid:19068402

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Ferguson B,
    3. Matyszak MK,
    4. Esiri MM, et al

    . Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393–99 doi:10.1093/brain/120.3.393 pmid:9126051

    Abstract/FREE Full Text
24. 24.↵
    2. Kornek B,
    3. Storch M,
    4. Weissert R, et al

    . Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol 2000;157:267–76 doi:10.1016/S0002-9440(10)64537-3 pmid:10880396

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Murakami R,
    3. Hirai T,
    4. Sugahara T, et al

    . Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology 2009;251:838–45 doi:10.1148/radiol.2513080899 pmid:19318585

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Beppu T,
    3. Inoue T,
    4. Shibata Y, et al

    . Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumours. J Neurooncol 2003;63:109–16 doi:10.1023/A:1023977520909 pmid:12825815

    CrossRefPubMed
27. 27.↵
    2. Goebell E,
    3. Fiehler J,
    4. Ding XQ, et al

    . Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patient: a combined diffusion tensor imaging and 1H-MR spectroscopy study. AJNR Am J Neuroradiol 2006;27:1427–31 pmid:16908551

    PubMed
28. 28.↵
    2. Ceccarelli A,
    3. Rocca M,
    4. Falini A, et al

    . Normal appearing white and grey matter damage in MS: a volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol 2007;254:513–18 doi:10.1007/s00415-006-0408-4 pmid:17401516

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Tsui EY,
    3. Leung WH,
    4. Chan JH, et al

    . Tumefactive demyelinating lesions by combined perfusion-weighted and diffusion weighted imaging. Comput Med Imaging Graph 2002;26:343–46 doi:10.1016/S0895-6111(02)00017-4 pmid:12204240

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Kirk J,
    3. Plumb J,
    4. Mirakhur M, et al

    . Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003;201:319–27 doi:10.1002/path.1434 pmid:14517850

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Proescholdt MA,
    3. Jacobson S,
    4. Tresser N, et al

    . Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 2002;61:914–25 doi:10.1093/jnen/61.10.914 pmid:12387457

    CrossRefPubMed
32. 32.↵
    2. Jackson JR,
    3. Seed MP,
    4. Kircher CH, et al

    . The codependence of angiogenesis and chronic inflammation. FASEB J 1997;11:457–65 pmid:9194526

    Abstract
33. 33.↵
    2. Ludwin S,
    3. Henry J,
    4. McFarland H

    . Vascular proliferation and angiogenesis in MS: clinical and pathogenic implications [abstract]. J Neuropathol Exp Neurol 2001;60:505
34. 34.↵
    2. Mangla R,
    3. Ginat DT,
    4. Kamalian S, et al

    . Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes. J Neurooncol 2014;116:325–31 doi:10.1007/s11060-013-1298-9 pmid:24178441

    CrossRefPubMed
35. 35.↵
    2. Hirunpat S,
    3. Sanghan N,
    4. Watcharakul C, et al

    . Is apparent diffusion coefficient value measured on picture archiving and communication system workstation helpful in prediction of high-grade meningioma? Hong Kong J Radiol 2016;19:84–90 doi:10.12809/hkjr1615346

    CrossRef